Enhabit Past Earnings Performance
Past criteria checks 0/6
Enhabit's earnings have been declining at an average annual rate of -58.8%, while the Healthcare industry saw earnings declining at 1.6% annually. Revenues have been declining at an average rate of 1.7% per year.
Key information
-58.8%
Earnings growth rate
-86.1%
EPS growth rate
| Healthcare Industry Growth | 15.7% |
| Revenue growth rate | -1.7% |
| Return on equity | -11.5% |
| Net Margin | -8.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Enhabit makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,044 | -83 | 439 | 0 |
| 31 Dec 23 | 1,046 | -80 | 442 | 0 |
| 30 Sep 23 | 1,049 | -169 | 432 | 0 |
| 30 Jun 23 | 1,056 | -158 | 430 | 0 |
| 31 Mar 23 | 1,062 | -64 | 425 | 0 |
| 31 Dec 22 | 1,071 | -40 | 415 | 0 |
| 30 Sep 22 | 1,084 | 84 | 414 | 0 |
| 30 Jun 22 | 1,092 | 97 | 410 | 0 |
| 31 Mar 22 | 1,110 | 109 | 414 | 0 |
| 31 Dec 21 | 1,107 | 111 | 413 | 0 |
| 31 Dec 20 | 1,078 | 75 | 398 | 0 |
| 31 Dec 19 | 1,092 | 24 | 466 | 0 |
Quality Earnings: X34 is currently unprofitable.
Growing Profit Margin: X34 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: X34 is unprofitable, and losses have increased over the past 5 years at a rate of 58.8% per year.
Accelerating Growth: Unable to compare X34's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: X34 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-4.2%).
Return on Equity
High ROE: X34 has a negative Return on Equity (-11.53%), as it is currently unprofitable.